|

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

RECRUITINGSponsored by Dana-Farber Cancer Institute
Actively Recruiting
SponsorDana-Farber Cancer Institute
Started2023-01-01
Est. completion2027-08-01
Eligibility
Age15 Years+
Healthy vol.Accepted
Locations4 sites

Summary

The purpose of this research study is to learn more about lung cancer (NSCLC or SCLC) diagnosed in adults at ages 45 or younger.

Eligibility

Age: 15 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age 45 and under at lung cancer diagnosis
* Pathologically confirmed bronchogenic lung carcinoma (NSCLC or SCLC of any stage) at any treatment time point
* Provision of written informed consent
* Willingness to undergo no more than two (2) peripheral blood draws in a four (4) week period, with no more than 50 ml peripheral blood collected over eight (8) weeks
* Individuals under age 18 are eligible for study if they meet defined criteria; in addition, consent for participation must be given by a legal guardian or parent

Exclusion Criteria:

* Individuals who decline to sign consent
* Individuals who are unable to give consent or assent and are without a designated healthcare proxy
* Compromise of patient diagnosis or staging if tissue is used for research

Conditions5

CancerLung CancerNUT CarcinomaNon Small Cell Lung CancerSmall Cell Lung Carcinoma

Locations4 sites

Massachusetts General Hospital
Boston, Massachusetts, 02114
Jessica Line, MD617-724-1134jjlin1@partners.org
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115
Daniel Costa, MD PhD617-667-9236
Brigham and Women's Hospital
Boston, Massachusetts, 02115
Pasi A Janne, MD, PhD617-632-6036Pasi_Janne@dfci.harvard.edu
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115
Pasi A Janne, MD, PhD617-632-6036Pasi_Janne@dfci.harvard.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.